Motivational Enhancement Therapy to Improve Treatment Utilization in Pregnant Substance Users - 1

NCT ID: NCT00078143

Last Updated: 2017-01-12

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

PHASE3

Total Enrollment

200 participants

Study Classification

INTERVENTIONAL

Study Start Date

2003-10-31

Study Completion Date

2006-04-30

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The purpose of this study is to compare Motivational Enhancement Therapy (MET) with standard drug abuse treatment among pregnant women.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Substance-Related Disorders

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Primary Study Purpose

TREATMENT

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Behavior Therapy

Intervention Type BEHAVIORAL

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Pregnancy \<30 weeks
* Have not attended drug treatment in past 28 days
* Not needing residential treatment (except detox)
* Not at risk for suicide/homicide
* Have no pending legal charges (except drug treatment)
Minimum Eligible Age

18 Years

Maximum Eligible Age

99 Years

Eligible Sex

FEMALE

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

University of Cincinnati

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

University of Cincinnati

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Theresa Winhusen, Ph.D.

Role: PRINCIPAL_INVESTIGATOR

University of Cincinnati

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Midtown Community Mental Health Center

Indianapolis, Indiana, United States

Site Status

Jefferson Alcohol & Drug Abuse Center

Louisville, Kentucky, United States

Site Status

Eleonore Hutzel Recovery Center

Detroit, Michigan, United States

Site Status

Milagro Clinic

Albuquerque, New Mexico, United States

Site Status

Milagro

Albuquerque, New Mexico, United States

Site Status

Coastal Horizons Center, Inc.

Wilmington, North Carolina, United States

Site Status

Countries

Review the countries where the study has at least one active or historical site.

United States

References

Explore related publications, articles, or registry entries linked to this study.

Osterman R, Lewis D, Winhusen T. Efficacy of motivational enhancement therapy to decrease alcohol and illicit-drug use in pregnant substance users reporting baseline alcohol use. J Subst Abuse Treat. 2017 Jun;77:150-155. doi: 10.1016/j.jsat.2017.02.003. Epub 2017 Feb 21.

Reference Type DERIVED
PMID: 28254158 (View on PubMed)

Winhusen T, Lewis D. Cigarette smoking in pregnant substance users: Association with substance use and desire to quit. J Addict Dis. 2017 Jan-Mar;36(1):88-91. doi: 10.1080/10550887.2016.1254992. Epub 2016 Nov 1.

Reference Type DERIVED
PMID: 27802114 (View on PubMed)

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

NIDA-CTN-0013-1

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

Reducing Barriers to Drug Abuse Treatment Services
NCT00273845 COMPLETED PHASE2/PHASE3
Monitoring and Feedback in Substance Abuse Treatment
NCT01465490 COMPLETED PHASE1/PHASE2